SBI Life Insurance Company Ltd
SBI Life Insurance Company Ltd is engaged in the business of life insurance and annuity. It was started as a Joint-venture between State Bank of India and BNP Paribas Cardif S.A.[1]
- Market Cap ₹ 1,41,827 Cr.
- Current Price ₹ 1,416
- High / Low ₹ 1,572 / 1,130
- Stock P/E 76.3
- Book Value ₹ 144
- Dividend Yield 0.19 %
- ROCE 15.5 %
- ROE 14.0 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company is expected to give good quarter
Cons
- Stock is trading at 9.94 times its book value
- Tax rate seems low
- Earnings include an other income of Rs.1,761 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Insurance Industry: Finance & Investments
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
13,760 | 14,870 | 17,258 | 23,299 | 19,324 | 30,548 | 34,068 | 44,604 | 43,798 | 81,913 | 82,983 | 80,636 | 117,028 | |
13,331 | 14,443 | 16,747 | 22,505 | 18,404 | 29,479 | 32,736 | 43,130 | 42,447 | 81,040 | 82,254 | 80,420 | 116,741 | |
Operating Profit | 429 | 427 | 511 | 794 | 920 | 1,068 | 1,332 | 1,474 | 1,351 | 872 | 730 | 216 | 287 |
OPM % | 3% | 3% | 3% | 3% | 5% | 4% | 4% | 3% | 3% | 1% | 1% | 0% | 0% |
214 | 292 | 344 | 183 | 129 | 139 | 156 | 266 | 529 | 867 | 1,032 | 1,758 | 1,761 | |
Interest | 4 | 4 | 5 | 4 | 5 | 5 | 6 | 8 | 0 | 0 | 0 | 0 | 0 |
Depreciation | 34 | 25 | 35 | 34 | 37 | 48 | 59 | 92 | 89 | 99 | 75 | 68 | 0 |
Profit before tax | 604 | 690 | 816 | 939 | 1,007 | 1,154 | 1,422 | 1,642 | 1,790 | 1,640 | 1,687 | 1,906 | 2,048 |
Tax % | 8% | 9% | 11% | 13% | 16% | 17% | 19% | 19% | 21% | 11% | 11% | 10% | |
556 | 630 | 728 | 815 | 844 | 955 | 1,150 | 1,327 | 1,422 | 1,456 | 1,506 | 1,721 | 1,860 | |
EPS in Rs | 5.56 | 6.30 | 7.28 | 8.15 | 8.44 | 9.55 | 11.50 | 13.27 | 14.22 | 14.56 | 15.05 | 17.19 | 18.58 |
Dividend Payout % | 9% | 8% | 14% | 15% | 14% | 16% | 17% | 15% | 0% | 17% | 13% | 15% |
Compounded Sales Growth | |
---|---|
10 Years: | 18% |
5 Years: | 19% |
3 Years: | 23% |
TTM: | 46% |
Compounded Profit Growth | |
---|---|
10 Years: | 11% |
5 Years: | 8% |
3 Years: | 7% |
TTM: | 15% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 18% |
3 Years: | 16% |
1 Year: | 27% |
Return on Equity | |
---|---|
10 Years: | 17% |
5 Years: | 15% |
3 Years: | 14% |
Last Year: | 14% |
Balance Sheet
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,001 | 1,001 |
Reserves | 1,156 | 1,736 | 2,356 | 3,056 | 3,733 | 4,552 | 5,528 | 6,576 | 7,743 | 9,400 | 10,622 | 12,017 | 12,968 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
46,085 | 50,978 | 57,284 | 70,064 | 78,696 | 96,687 | 115,193 | 139,157 | 156,837 | 216,430 | 261,715 | 301,669 | 338,453 | |
Total Liabilities | 48,240 | 53,714 | 60,640 | 74,121 | 83,429 | 102,240 | 121,720 | 146,734 | 165,580 | 226,830 | 273,337 | 314,686 | 352,422 |
263 | 283 | 304 | 292 | 301 | 507 | 511 | 563 | 568 | 564 | 919 | 867 | 542 | |
CWIP | 2 | 3 | 4 | 7 | 146 | 31 | 70 | 32 | 13 | 1 | 3 | 1 | 0 |
Investments | 44,778 | 50,047 | 56,275 | 69,385 | 77,843 | 95,830 | 114,436 | 139,325 | 158,813 | 218,756 | 264,437 | 303,988 | 342,174 |
3,198 | 3,382 | 4,058 | 4,437 | 5,139 | 5,871 | 6,703 | 6,814 | 6,186 | 7,509 | 7,978 | 9,830 | 9,705 | |
Total Assets | 48,240 | 53,714 | 60,640 | 74,121 | 83,429 | 102,240 | 121,720 | 146,734 | 165,580 | 226,830 | 273,337 | 314,686 | 352,422 |
Cash Flows
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
6,468 | 1,130 | 166 | 2,711 | 5,778 | 8,525 | 10,395 | 13,473 | 19,299 | 23,878 | 21,852 | 28,656 | |
-4,968 | -227 | -708 | -178 | -7,204 | -9,032 | -8,910 | -13,552 | -16,986 | -19,203 | -21,611 | -30,203 | |
0 | -58 | -58 | -117 | -144 | -144 | -221 | -241 | -198 | 3 | -231 | -415 | |
Net Cash Flow | 1,500 | 845 | -600 | 2,416 | -1,570 | -651 | 1,264 | -321 | 2,114 | 4,677 | 10 | -1,962 |
Ratios
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventory Days | ||||||||||||
Days Payable | ||||||||||||
Cash Conversion Cycle | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Working Capital Days | -11 | -5 | -2 | 0 | -6 | 3 | 3 | 4 | 11 | 1 | -3 | 1 |
ROCE % | 32% | 28% | 27% | 25% | 23% | 23% | 24% | 22% | 22% | 17% | 15% | 15% |
Documents
Announcements
- Intimation Under Regulation 30 Read With Para A Of Part A Of Schedule III Of The SEBI (LODR) Regulations, 2015 22 Apr
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
18 Apr - Company will be hosting an earnings conference call with analysts and investors at 16:30 (IST) on April 26, 2024 to update the performance of the …
- Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 18 Apr
- Certificate For Sub-Regulation (9) Of Regulation 40 Of The SEBI (LODR) Regulations, 2015 12 Apr
- Board Meeting Intimation for Considering And Approving Audited Financial Result For The Quarter And Year Ended March 31, 2024. 10 Apr
Annual reports
Concalls
-
Feb 2024Transcript PPT
-
Oct 2023Transcript PPT
-
Jul 2023Transcript PPT
-
Jun 2023TranscriptNotesPPT
-
May 2023TranscriptPPT
-
Jan 2023TranscriptPPT
-
Nov 2022TranscriptPPT
-
Aug 2022TranscriptPPT
-
May 2022TranscriptPPT
-
May 2020TranscriptNotesPPT
-
Jan 2018TranscriptNotesPPT
Ratios FY21
Solvency Ratio - 215%[1]
Claim Settlement Ratio - 100%[2]
Cost Ratio - 8%
Commission Ratio - 3.5%
Persistency Ratio (13 months) - 88%
Persistency Ratio (61 months) - 62%
VNB Margin - 20%[1]
Net Retention Ratio - 99%[3]